GT BIOPHARMA, INC. Warrants Not Settleable in Cash, Fair Value Disclosure
GT BIOPHARMA, INC. (GTBP) had Warrants Not Settleable in Cash, Fair Value Disclosure of $72.00 thousand as of 2012-06-30, per its 10-Q/A filed 2012-09-13.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2012-09-13
- 2012-06-30: Warrants Not Settleable in Cash, Fair Value Disclosure $72.00K.
- 2011-12-31: Warrants Not Settleable in Cash, Fair Value Disclosure $39.00K.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2012-06-30 | $72.00K 10-Q/A · filed 2012-09-13 |
| 2011-12-31 | $39.00K 10-Q/A · filed 2012-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |